Pharmacists in Ontario are reporting a critical shortage of several prescription medications that have remained on backorder for a few weeks [1].

These shortages threaten patient health by preventing the fulfillment of essential prescriptions. When medication is unavailable, patients may face interrupted treatment cycles or be forced to seek alternative therapies that require new physician approvals.

Kyro Maseh, a pharmacist in Toronto's Beaches neighbourhood, said the current situation has left providers without a clear timeline for restocking. The lack of visibility into the supply chain makes it difficult for pharmacies to manage patient expectations or suggest alternatives.

“We’re running blind,” Maseh said [1].

The disruptions have created a growing disconnect between healthcare providers and their patients. Maseh said that patients are showing up with prescriptions they cannot fill because the medication is on backorder [1].

Pharmacy owners and patients are now urging both the provincial and federal governments to intervene. They are calling for a more robust inventory system to prevent supply-chain disruptions from impacting the delivery of medicine to the public [1, 2].

While the specific medications affected were not listed in the reports, the impact is being felt across the province. The instability in the supply chain suggests a systemic failure in how inventory is tracked, and distributed before it reaches local pharmacies [2].

““We’re running blind.””

This situation highlights a vulnerability in the Canadian pharmaceutical supply chain, where a reliance on lean inventory and global logistics can lead to localized shortages. If provincial and federal authorities do not implement better tracking and stockpiling mechanisms, the healthcare system may see an increase in preventable complications due to medication non-adherence.